NCT04983901 2024-11-04PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINM.D. Anderson Cancer CenterPhase 2 Completed100 enrolled 38 charts
NCT02732327 2017-07-21Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With CancerForest LaboratoriesPhase 2 Terminated2 enrolled 2 charts